Related Experiment Video
Updated: Jul 6, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Vaccines to combat smoking
Rick A Bevins1, Jamie L Wilkinson, Sam D Sanderson
1University of Nebraska-Lincoln, Department of Psychology, 238 Burnett Hall, Lincoln, NE 68588-0308, USA. rbevins1@unl.edu
Background:
Current US FDA-approved biological therapies for treating smoking target central nervous system processes. Although these therapies have had some success, relapse within a year is still high. Clearly additional strategies are needed to aid individuals in maintaining abstinence.
Objective/Methods:
We briefly discuss promising research using vaccines to combat smoking and then identify some potentially important directions for future research.
Results/Conclusions:
Immunization with a nicotine vaccine generates drug-specific antibodies that sequester some of the nicotine in the peripheral circulation preventing it from entering the brain, thus decreasing its addictive effects. Albeit promising, much more research is necessary to identify more efficacious vaccine designs and formulations, as well as optimal immunization regimens. A further understanding of the factors contributing to the substantial individual differences in immunogenicity to these vaccines and how to best use vaccines in combination with other treatment strategies will increase the success of intervention efforts.
Insights
Nicotine vaccines offer a novel approach to smoking cessation by creating antibodies that block nicotine from reaching the brain. Further research is needed to optimize vaccine efficacy and combination therapies for sustained abstinence.
Area of Science:
- Pharmacology
- Immunology
- Addiction Medicine
Background:
- Current smoking cessation therapies primarily target central nervous system pathways.
- High relapse rates within one year indicate a need for novel treatment strategies.
- Additional interventions are crucial for supporting long-term smoking abstinence.
Purpose of the Study:
- To review the potential of nicotine vaccines for smoking cessation.
- To identify future research directions for vaccine-based smoking cessation strategies.
Main Methods:
- Review of current research on nicotine vaccines.
- Identification of key areas for future investigation in vaccine development and application.
Main Results:
- Nicotine vaccines generate antibodies that sequester nicotine peripherally, reducing brain entry and addictive effects.
- Vaccine efficacy is influenced by design, formulation, and immunization regimens.
- Individual differences in immunogenicity present a challenge for vaccine effectiveness.
Conclusions:
- Nicotine vaccines show promise as a complementary smoking cessation tool.
- Further research is essential to enhance vaccine efficacy, optimize delivery, and understand individual responses.
- Investigating combination therapies involving vaccines and other treatments can improve cessation success rates.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Vaccines
Smallpox
Respiratory Syncytial Virus Disease

